For more information or confidential assistance
se habla español

FDA Bone Graft Warning Issued for Minors

A new FDA bone graft warning has been issued, advising doctors to avoid off-label use of certain bone graft substitutes in patients with bone disorders, who are younger than 18 years old ─ this includes Medtronic’s Infuse bone graft. The FDA noted that these bone graft substitutes could cause serious... Read more »

Medtronic Infuse Bone Graft Settlement Reached

INFUSE lawsuit settlement
A Medtronic INFUSE bone graft settlement was recently announced, with the medical technology company agreeing to pay $22 million to settle approximately 1,000 legal claims over the controversial spine surgery product. Medtronic is also setting an additional $140 million aside to fund an even larger number of expected claims. The... Read more »